23andMe , a genetics examination society , has been afford the green light by the Food and Drug Administration ( FDA ) to resume providing U.S. customers with wellness selective information based on their DNA tests . The Silicon Valley - based biotech company wasforced to cease providing wellness datafrom personal genome examination after it fail to receive market authority from the FDA over headache that its result might be inaccurate .
Two twelvemonth on , 23andMe has announced that they will be able-bodied to fully resume their service in the U.S. after get FDA favorable reception . For the past two years , the ship’s company was still able to sell information about stock but was barred from free data on wellness and carrier status . Along with this good news from the FDA , 23andMe got a sleeknew websiteand a $ 115 million ( £ 75 million)injection of cashfrom investor last week
talk toThe Associated Press , Anne Wojcicki , the company ’s Colorado - father and CEO , said , " Today we ’ve successfully established a model for working with the FDA to bring back report directly to the consumer . And we ’ll continue to do work to hear and make for all of this data back . "
She added , " We took a tidy sum of the feedback that we ’d gotten over the last seven years and then contain that with all the FDA feedback into a whole unexampled reputation data format . ”
The party name , 23andMe , come from the 23 pair of chromosome in world . Using deoxyribonucleic acid take from spit , the company can give you information on whether you are a carrier for inherited conditions such as cystic fibrosis , sickle cellular phone anemia and hereditary hearing loss . As well as continuing their parentage services , they can now also provide reports of whether you ’re potential to get an alcohol loaded chemical reaction , your probability for enjoying caffeine and your muscle composition .
The company has been able to betray ancestry and health - base info in Canada since October 2014 and in the United Kingdom since December 2014 .
However , there have been some changes to their original overhaul . First of all , it come out their services will be made more expensive , break down from $ 99 ( £ 65 ) to $ 199 ( £ 130 ) . Additionally , it will not be capable to sell all of the 250 reports included in its original overhaul , which purportedly distinguish users if they were genetically susceptible to diseases such as Parkinson ’s and Alzheimer ’s .
